Concepedia

Publication | Open Access

Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial

DOIFull Paper Access

40

Citations

39

References

2020

Year

Lotfollah Davoodi, Seyed Mohammad Abedi, Ebrahim Salehifar, Reza Alizadeh‐Navaei, Hamed Rouhanizadeh, Ghasemali Khorasani, Seyed Jalal Hosseinimehr
International Journal of Clinical Practice

Abstract

This trial suggests that FBX is as an alternative treatment to HCQ for COVID-19 infection and may be considered in patients with a contraindication or precaution to HCQ.

References

YearCitations

Page 1